Latest Articles
Latest
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
WM-NET.org has launched!
Check out the new site at WM-NET.org A new era for Waldenstrom’s research has arrived! IWMF is thrilled to share the launch of the WM-NET website. This is a national collaboration of 24 leading U.S. academic medical centers advancing translational research and...
The Lowdown on Sugar and Cancer
with Kirstin NussgruberThursday, February 12th at 1pm ETJoin board-certified nutrition consultant and cancer survivor Kirstin Nussgruber for an evidence-based webinar on the links between sugar and cancer. This session clarifies latest research on how sugar affects...
The “What Ifs” of WM: Adopting a Positive Mindset
with Deborah KellyThursday, January 22nd at 12pm ETWhat if it works out? What if it’s all ok? What if something good happens in spite of your WM diagnosis? In this interactive webinar, we’ll meet an inspiring mother of 4 who was diagnosed with Waldenstrom at age 37....
The Joy of Music
with Declan CosgroveThursday, Dec 11th at 1pm EST / 6pm GMTThere is a strong link between music and physical and mental health. Music can influence hormones, reduce stress, and improve mood. Just listening to music is very restorative - but playing music is even...
Integrative Oncology – Caring for the Whole Person
with Jacqui Bauers, LMT, CPMTThursday, November 20, 2025 1:00 PM estJoin us for an interactive and informative webinar exploring the power of Integrative Oncology—a patient-centered approach that blends conventional cancer treatments with evidence-based complementary...
Subscribe Today!
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean scelerisque suscipit condimentum. Vestibulum in scelerisque eros. Fusce sed massa vel sem commodo.
Featured Story
Lorem ipsum dolor sit consectetur adipiscing elit.
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas non nisi. Curabitur aliquet quam id dui posuere blandit. Curabitur arcu erat, accumsan id imperdiet et, porttitor at sem. Sed porttitor lectus nibh. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. Nulla quis lorem ut libero malesuada feugiat.
Pellentesque in ipsum id orci porta dapibus. Nulla porttitor accumsan tincidunt. Nulla quis lorem ut libero malesuada feugiat. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia Curae; Donec velit neque, auctor sit amet aliquam vel, ullamcorper sit amet ligula. Vivamus suscipit tortor eget felis porttitor volutpat. Proin eget tortor risus. Cras ultricies ligula sed magna dictum porta. Proin eget tortor risus. Vivamus suscipit tortor eget felis porttitor volutpat.
Featured Author
Vestibulum Malesuada Non Magna Lacinia
Proin eget tortor risus. Praesent sapien massa, convallis a pellentesque nec, egestas no
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
WM-NET.org has launched!
Check out the new site at WM-NET.org A new era for Waldenstrom’s research has arrived! IWMF is thrilled to share the launch of the WM-NET website. This is a national collaboration of 24 leading U.S. academic medical centers advancing translational research and...
The Lowdown on Sugar and Cancer
with Kirstin NussgruberThursday, February 12th at 1pm ETJoin board-certified nutrition consultant and cancer survivor Kirstin Nussgruber for an evidence-based webinar on the links between sugar and cancer. This session clarifies latest research on how sugar affects...
The “What Ifs” of WM: Adopting a Positive Mindset
with Deborah KellyThursday, January 22nd at 12pm ETWhat if it works out? What if it’s all ok? What if something good happens in spite of your WM diagnosis? In this interactive webinar, we’ll meet an inspiring mother of 4 who was diagnosed with Waldenstrom at age 37....
Popular Categories
Categories
Gadgets & Devices
Fashion
Travel
Trending Now
Hot
Latest Trending
Featured Trending
Staff Picks
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
Vestibulum Malesuada Non Magna Lacinia
Home Office
Expansion of IMBRUVICA® (ibrutinib) Label in the U.S.
U.S. Food and Drug Administration (FDA) Approves a Label Expansion for IMBRUVICA® (ibrutinib) On February 26th, Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics LLC, an AbbVie Company, announced that the U.S. Food and Drug...
Registration for Our Educational Forums is Open!
Save your spot - in Athens, Greece - or in Columbus, Ohio! We’re excited to announce that registration is now open for both 2026 IWMF Educational Forums—bringing together the global Waldenstrom macroglobulinemia (WM) community for education, connection, and...
WM-NET.org has launched!
Check out the new site at WM-NET.org A new era for Waldenstrom’s research has arrived! IWMF is thrilled to share the launch of the WM-NET website. This is a national collaboration of 24 leading U.S. academic medical centers advancing translational research and...
The Lowdown on Sugar and Cancer
with Kirstin NussgruberThursday, February 12th at 1pm ETJoin board-certified nutrition consultant and cancer survivor Kirstin Nussgruber for an evidence-based webinar on the links between sugar and cancer. This session clarifies latest research on how sugar affects...
The “What Ifs” of WM: Adopting a Positive Mindset
with Deborah KellyThursday, January 22nd at 12pm ETWhat if it works out? What if it’s all ok? What if something good happens in spite of your WM diagnosis? In this interactive webinar, we’ll meet an inspiring mother of 4 who was diagnosed with Waldenstrom at age 37....
Our Recommended Products
Shop
